In this cellular context, chip-seq studies indicate that the DNA binding of RAR and ERα throughout the genome is highly coincident and this coincidence is at the basis of a widespread crosstalk between ATRA and estrogen signaling, which results in an antagonistic regulation of breast cancer-associated genes [25, 35]. The gene discussed is RARA; the disease is breast carcinoma.